Papillary serous cystadenocarcinoma
| Papillary serous cystadenocarcinoma | |
|---|---|
.jpg)
| |
| Synonyms | |
| Pronounce | |
| Field | |
| Symptoms | |
| Complications | |
| Onset | |
| Duration | |
| Types | |
| Causes | |
| Risks | |
| Diagnosis | |
| Differential diagnosis | |
| Prevention | |
| Treatment | |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | |
Papillary Serous Cystadenocarcinoma
Papillary serous cystadenocarcinomas are the most prevalent form of malignant ovarian cancer, accounting for approximately 26 percent of ovarian tumors in women over the age of 20 in the United States. Characterized by their aggressive nature, these tumors often present challenges in early detection and treatment.
Overview
Papillary serous cystadenocarcinomas are known for their malignant potential and tendency to metastasize. They are commonly diagnosed in advanced stages, as early signs of the disease are typically absent. The spread of these tumors often occurs along the peritoneum, contributing to the complexity of treatment.
Histopathology
Histopathological examination of papillary serous cystadenocarcinomas can reveal distinct features such as:
- Psammoma bodies - Calcified structures that are often present in these types of tumors.
Diagnosis
Diagnosis of papillary serous cystadenocarcinoma typically involves a combination of:
- Pelvic examinations
- Imaging studies such as Ultrasound, CT scans, or MRI
- CA-125 blood test, which may show elevated levels in the presence of ovarian cancer
- Biopsy and histopathological analysis to confirm the presence of cancerous cells
Treatment
The standard treatment for papillary serous cystadenocarcinoma often includes:
- Surgery to remove as much of the tumor as possible
- Chemotherapy to target cancer cells that may have spread beyond the ovaries
- Targeted therapies and hormone therapies may also be used depending on the individual case and tumor characteristics
Prognosis
The prognosis for patients with papillary serous cystadenocarcinoma can vary based on the stage at diagnosis and the effectiveness of treatment. Generally, the five-year relative survival rate serves as a benchmark for prognosis, with early detection and treatment improving outcomes.
See Also
 | |
|---|---|
 |
 |
| Glandular and epithelial cancer | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Tumors of the female urogenital system | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
